Robust immune response to COVID-19 vaccination in the island population of Greenland
Our findings show that Greenlanders exhibit a robust and lasting immune response, both humoral and cellular, comparable to other population groups up to at least 11 months after the second vaccine dose. These results corroborate the hypothesis that vaccines contributed to the mild impact of the COVID-19 pandemic in the Greenlandic population.
Authors
- Anders Koch (ORCID: https://orcid.org/0000-0001-9205-1048)
- Lennart Friis‐Hansen (ORCID: https://orcid.org/0000-0002-7222-0163)
- Kåre Mølbak (ORCID: https://orcid.org/0000-0002-3100-4990)
- Mie Møller (ORCID: https://orcid.org/0009-0001-3576-1577)
- Mikael Andersson (ORCID: https://orcid.org/0000-0002-0114-2057)
- Nikolai Kirkby (ORCID: https://orcid.org/0000-0001-7498-2738)
- Peter Vedsted (ORCID: https://orcid.org/0000-0003-2113-5599)
- Christine Dilling-Hansen (ORCID: https://orcid.org/0000-0002-7818-8766)
Institutions
- Statens Serum Institut (DK)
- University of Copenhagen (DK)
- Ilisimatusarfik (GL)
- Aarhus University (DK)
- Bispebjerg Hospital (DK)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
- Grønlands Naturinstitut (GL)
- Queen Ingrid's Hospital (GL)
Publication Details
- Journal
- Communications Medicine
- Published
- 2024-09-06
- DOI
- https://doi.org/10.1038/s43856-024-00602-y
- Citations
- 1
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- Pinngortitaleriffik
- Rigshospitalet
- Kong Christian den Tiendes Fond
- Grosserer L. F. Foghts Fond
- Bispebjerg Hospital